173 related articles for article (PubMed ID: 36424008)
21. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
[TBL] [Abstract][Full Text] [Related]
22. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.
Mohanty S; Mohanty P; Trivedi C; Gianni C; Bai R; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Hranitzky PM; Al-Ahmad A; Bailey S; Di Biase L; Natale A
Heart Rhythm; 2015 Sep; 12(9):1963-71. PubMed ID: 26051531
[TBL] [Abstract][Full Text] [Related]
23. Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: An Evaluation of Cohorts With and Without Structural Heart Disease.
Perego GB; Iacopino S; Pieragnoli P; Verlato R; Arena G; Molon G; Rovaris G; Manfrin M; Mantica M; Senatore G; Stabile G; Bertaglia E; Brasca F; Tondo C;
Heart Lung Circ; 2020 Jul; 29(7):1078-1086. PubMed ID: 31594723
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Elevated Left Atrial Pressure in Sinus Rhythm After Cardioversion on Outcomes After Catheter Ablation for Atrial Fibrillation.
Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
J Cardiovasc Electrophysiol; 2016 Jul; 27(7):813-9. PubMed ID: 27090869
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials.
Kampaktsis PN; Oikonomou EK; Y Choi D; Cheung JW
J Interv Card Electrophysiol; 2017 Dec; 50(3):253-260. PubMed ID: 28887742
[TBL] [Abstract][Full Text] [Related]
26. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
[TBL] [Abstract][Full Text] [Related]
27. Left Atrial Size and Left Ventricular End-Systolic Dimension Predict the Progression of Paroxysmal Atrial Fibrillation After Catheter Ablation.
Liao YC; Liao JN; Lo LW; Lin YJ; Chang SL; Hu YF; Chao TF; Chung FP; Tuan TC; Te AL; Walia R; Yamada S; Lin CH; Lin CY; Chang YT; Allamsetty S; Yu WC; Huang JL; Wu TJ; Chen SA
J Cardiovasc Electrophysiol; 2017 Jan; 28(1):23-30. PubMed ID: 27779351
[TBL] [Abstract][Full Text] [Related]
28. The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.
Chen YY; Chang HC; Lin YJ; Chien KL; Hsieh YC; Chung FP; Lin CH; Lip GYH; Chen SA
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3775. PubMed ID: 38340046
[TBL] [Abstract][Full Text] [Related]
29. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
[TBL] [Abstract][Full Text] [Related]
30. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion.
Fujimoto Y; Yodogawa K; Takahashi K; Tsuboi I; Hayashi H; Uetake S; Iwasaki YK; Hayashi M; Miyauchi Y; Shimizu W
Heart Vessels; 2017 Nov; 32(11):1375-1381. PubMed ID: 28631077
[TBL] [Abstract][Full Text] [Related]
32. Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study).
Creta A; Providência R; Adragão P; de Asmundis C; Chun J; Chierchia G; Defaye P; Schmidt B; Anselme F; Finlay M; Hunter RJ; Papageorgiou N; Lambiase PD; Schilling RJ; Combes S; Combes N; Albenque JP; Pozzilli P; Boveda S
Am J Cardiol; 2020 Mar; 125(6):901-906. PubMed ID: 31973808
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods.
Baba M; Yoshida K; Naruse Y; Hattori A; Yui Y; Kimata A; Ito Y; Tsumagari Y; Tsuneoka H; Shinoda Y; Harunari T; Hanaki Y; Hasebe H; Misaki M; Abe D; Nogami A; Ieda M; Takeyasu N
Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932837
[No Abstract] [Full Text] [Related]
34. QTc interval predicts outcome of catheter ablation in paroxysmal atrial fibrillation patients with type 2 diabetes mellitus.
Ma N; Wu XY; Ma CS; Liu N; Bai R; Du X; Ruan YF; Dong JZ
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):646-652. PubMed ID: 27752887
[TBL] [Abstract][Full Text] [Related]
35. Additional Low-Voltage-Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial.
Masuda M; Asai M; Iida O; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Okuno S; Hata Y; Mano T
J Am Heart Assoc; 2020 Jul; 9(13):e015927. PubMed ID: 32578466
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
[No Abstract] [Full Text] [Related]
37. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for late recurrence in patients with nonvalvular atrial fibrillation after radiofrequency catheter ablation.
Peng Z; Wen-Heng L; Qing Z; Pin S; Shang-Lang C; Mao-Jing W; Ya-Qi P
Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12924. PubMed ID: 34882911
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Efficacy of Empiric Thoracic Vein Isolation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation in Patients Without Structural Heart Disease.
Ejima K; Henmi R; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
J Cardiovasc Electrophysiol; 2017 Mar; 28(3):266-272. PubMed ID: 28054729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
